Skip to content

Clinical trials

Phase 3 Anorexia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anorexia Phase: Phase 3 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20031
20041
20063
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology4
Par Pharmaceutical, Inc.2
Wake Forest University Health Sciences2
Bristol-Myers Squibb1
M.D. Anderson Cancer Center1
Mayo Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anorexia11
Cachexia10
Lung Neoplasms4
Body Weight3
Weight Loss3
Carcinoma, Non-Small-Cell Lung2
Acquired Immunodeficiency Syndrome1
Body Weight Changes1
Esthesioneuroblastoma, Olfactory1
Fatigue1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.